| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/04/2002 | US6399594 With water insoluble starch carrier; allows dry storage and lower doses of active ingredient |
| 06/04/2002 | US6399593 Contraceptives |
| 06/04/2002 | US6399592 Bishphosphonate/estrogen synergistic therapy for treating and preventing bone loss |
| 06/04/2002 | US6399591 Chargeable pharmaceutical tablets |
| 06/04/2002 | US6399590 Phosphoglycolipid and methods for its use |
| 06/04/2002 | US6399589 Viricides; antitumor agents |
| 06/04/2002 | US6399588 Cancer treatment method utilizing plasmids suitable for IL-2 expression |
| 06/04/2002 | US6399583 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains, process for production and uses thereof |
| 06/04/2002 | US6399582 Ketolide antibacterials |
| 06/04/2002 | US6399581 Anticoagulants |
| 06/04/2002 | US6399580 Inhibitor of an enzyme having beta -glucosidase activity, or a glycosphingolipid, particularly glucocerebroside |
| 06/04/2002 | US6399579 Compositions comprising icariside I and anhydroicaritin and methods for making the same |
| 06/04/2002 | US6399578 Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same |
| 06/04/2002 | US6399577 Central nervous system disorders |
| 06/04/2002 | US6399570 Mutant; active materials; proteolytic digestion of lactoferrin |
| 06/04/2002 | US6399566 Mixture containing capsaicine, histamine or plant extract |
| 06/04/2002 | US6399376 Modulation of vascular cell adhesive molecule expression through oligonucleotide interactions |
| 06/04/2002 | US6399328 Amino acid sequence; hybridization probes; amplification primers; anticarcinogenic agents; antitumor agents |
| 06/04/2002 | US6399297 Antisense modulation of expression of tumor necrosis factor receptor-associated factors (TRAFs) |
| 06/04/2002 | US6399139 Controlling material handling |
| 06/04/2002 | US6399107 Use of inhibitors of gag synthesis for the treatment of corneal haze |
| 06/04/2002 | US6399104 Pharmaceutical compositions |
| 06/04/2002 | US6399102 Aerodynamically light particles for pulmonary drug delivery |
| 06/04/2002 | US6399100 Controlled release pharmaceutical compositions containing tiagabine |
| 06/04/2002 | US6399096 Morphine and other drugs with fillers |
| 06/04/2002 | US6399093 Method and composition to treat musculoskeletal disorders |
| 06/04/2002 | US6399089 Mixture for thermogenic compounds to increase insulin sensitivity and inhibit re-uptake of serotonin |
| 06/04/2002 | US6399087 Dissolving in a solvent, emulsification with water and surfactant |
| 06/04/2002 | US6399086 Controlled release of drugs in small intestine, polymer matrices |
| 06/04/2002 | US6399083 Cosmetic skin care with extracts from chick peas and retinol and retinyl esters |
| 06/04/2002 | US6399082 Alpha-hydroxy acid, diol and semi-occlusion vehicles |
| 06/04/2002 | US6399079 Spill resistant pharmaceutical compositions in semi-solid form |
| 06/04/2002 | US6399072 Reverse addiction with isoflavones, lignans, sapoins, catechins and phenol acids |
| 06/04/2002 | US6399071 Removal of xenobodies from body fluid |
| 06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
| 06/04/2002 | US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection |
| 06/04/2002 | US6399052 Treating hair by targeting enzymes |
| 06/04/2002 | US6397849 Methods of ophthalmic administration |
| 06/04/2002 | CA2364108A1 Acylamino cyclopropane derivatives |
| 06/04/2002 | CA2302396C Allosteric adenosine receptor modulators |
| 06/04/2002 | CA2257016C Imidazolidin-4-one derivatives useful as anticancer agents |
| 06/04/2002 | CA2248366C Quinoxalinediones |
| 06/04/2002 | CA2239352C Injectable quinolone formulations |
| 06/04/2002 | CA2234367C Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 06/04/2002 | CA2227967C Topical compositions having improved skin feel |
| 06/04/2002 | CA2103725C Composition for use in transdermal administration |
| 06/04/2002 | CA2067929C Piperazine derivatives |
| 06/04/2002 | CA2060557C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
| 06/01/2002 | CA2364094A1 Astringent composition and method of use |
| 05/30/2002 | WO2002042772A1 TRIPEPTIDE OF FCηRIIA |
| 05/30/2002 | WO2002042491A2 Method for identifying compounds or lead structures against rna target motifs and rna/protein interactions |
| 05/30/2002 | WO2002042484A2 Method for producing pectin hydrolysis products |
| 05/30/2002 | WO2002042465A1 Production of stilbenes in transgenic plants and the method of producing thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042445A2 Differentiated cells suitable for human therapy |
| 05/30/2002 | WO2002042429A2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/30/2002 | WO2002042423A2 Antisense modulation of src-2 expression |
| 05/30/2002 | WO2002042412A2 Protease inhibitors and their pharmaceutical uses |
| 05/30/2002 | WO2002042335A1 Polysaccharide compound having immune stimulating activity |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042319A2 2-substituted estrogens as antiangiogenic agents |
| 05/30/2002 | WO2002042315A2 Macrolide solvates |
| 05/30/2002 | WO2002042311A2 Biotin derivatives, methods for making same and uses thereof as vectors |
| 05/30/2002 | WO2002042309A1 Indole derivatives and use thereof in medicines |
| 05/30/2002 | WO2002042306A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/30/2002 | WO2002042303A2 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 05/30/2002 | WO2002042302A1 Novel sulfonamide-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042301A1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042300A1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042299A1 Novel lactame-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042298A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 05/30/2002 | WO2002042295A2 Peptides as met-ap2 inhibitors |
| 05/30/2002 | WO2002042293A1 Isoquinoline derivatives useful in the treatment of cns disorders |
| 05/30/2002 | WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | WO2002042291A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors |
| 05/30/2002 | WO2002042290A1 New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof |
| 05/30/2002 | WO2002042280A2 Pyrimidine derivatives |
| 05/30/2002 | WO2002042279A1 Imidazolone derivatives for the treatment of viral diseases |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2002042277A1 Novel compounds for use as hiv protease inhibitors |
| 05/30/2002 | WO2002042276A1 Quarternary proforms of tertiary amine containing compounds |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042272A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 05/30/2002 | WO2002042271A2 Biphenylcarboxamides useful as lipid lowering agents |
| 05/30/2002 | WO2002042269A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | WO2002042268A2 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 05/30/2002 | WO2002042267A2 Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine |
| 05/30/2002 | WO2002042266A2 Process for the production of ceftifur sodium salt |
| 05/30/2002 | WO2002042265A2 Cyanoguanidine prodrugs |
| 05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | WO2002042256A2 N-alkylated gaba compounds, processes for their preparation and their use as medicaments |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2002042247A1 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage |
| 05/30/2002 | WO2002041925A1 Sterilisation of pharmaceuticals |
| 05/30/2002 | WO2002041924A1 Nitric oxide donor compounds and methods of treatment using same |
| 05/30/2002 | WO2002041919A1 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 05/30/2002 | WO2002041918A2 Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage |
| 05/30/2002 | WO2002041917A1 Ophthalmological preparations |
| 05/30/2002 | WO2002041916A2 Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors |